@article{6361e13da0fb4a05a19fcaa6fff73d0b,
title = "The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment",
author = "Martson, \{A. G.\} and Kim, \{H. Y.\} and B. Marais and Alffenaar, \{J. W.\}",
note = "Funding Information: The article is part of the activities of the TB Pharmacology Committee, Global Tuberculosis Network. A-GM was funded by Marie Sk{\l}odowska-Curie Actions, Brussels, Belgium (grant agreement no. 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015). Conflicts of interest: none declared.",
year = "2021",
month = may,
day = "1",
doi = "10.5588/ijtld.21.0072",
language = "English",
volume = "25",
pages = "336--339",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "5",
}